←
Penn Path & Lab Medicine5,422 posts
Penn Path & Lab Medicine avatar

Penn Path & Lab Medicine

@PennPathLabMed

Pathology and Laboratory Medicine @Penn: AP, CP, Research, Transfusion Medicine & Therapeutic Pathology, and Precision Dx

◷ Joined February 2014▧ 368 Photos and videos
Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Nov 12

We are looking forward to next Monday's Grand Rounds with Dr. Daniel Brat, MD, PhD! Should be an engaging session on how molecular discoveries continue to reshape the classification, diagnosis, and management of these tumors.

How has molecular pathology changed the way we view diffuse gliomas?   I'm delighted to welcome Dr. Daniel Brat, MD, PhD, Chair of Pathology at Northwestern University Feinberg School of Medicine, as an upcoming speaker in our Department of Pathology & Laboratory Medicine Grand Rounds series at Penn. Dr. Brat will present "A Contemporary Molecular View of Diffuse Gliomas," highlighting how molecular discoveries continue to reshape the classification, diagnosis, and management of these tumors. We look forward to an engaging discussion with one of the field's leading experts. @DanielJBrat @NorthwesternU @Sciencedirect #ScienceDirect @TheUSCAP @ESP_Pathology @AACR @IARCWHO @PennPathLabMed

Post attachment
Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Nov 10

Thank you to Daniel Ackerman, PhD, for his engaging Grand Rounds yesterday on the "Prevalence and Breakpoint Heterogeneity of PSIP1::TBL1X Fusions in Pancreatic Neuroendocrine Tumors". Always great to learn from our amazing colleagues in other areas of @PennMedicine!

Post attachment
Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Nov 9

🎉 Congratulations Jonni Moore, PhD, on receiving the Thomas Jefferson University (@JeffersonUniv) College of Life Sciences 2026 Distinguished Alumni Award! We could not think of a more deserving recipient and are so fortunate to have you on our team!

Post attachment
Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Nov 5

A great recent publication by @carina_dehner in @ModernPathology investigated a series of nine morphologically classic DNSMs and performed molecular testing & demonstrates the first recurrent molecular alteration identified in this tumor type. 🔬: modernpathology.org/article/…

Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Oct 30

There is a new 🎙️ Precision Pathology Podcast out! In this episode hear our chair @DrNetto in conversation with Dr. Yuri Tolkach as they discusses his team's study analyzing 2,791 whole-slide images using an open-source AI model. 🔬: podcasts.apple.com/us/podcas…

New Precision Pathology Podcast Episode! Can computational single-cell profiling of routine H&E slides reveal prognostic clues in lung adenocarcinoma? In this episode of Precision Pathology, Dr. Yuri Tolkach discusses his team's study analyzing 2,791 whole-slide images using an open-source AI model. The research identified lymphocyte-rich tumor environments as favorable prognostic markers, while granulocyte-rich stromal patterns were associated with poorer outcomes. The study also demonstrates how spatial immune-tumor interactions can provide powerful prognostic information, highlighting the potential of computational pathology to enhance risk stratification using standard pathology slides. Read manuscript here: doi.org/10.1016/j.prpath.202… Listen to the full episode: clientfiles.doctorpodcasting… Also available on Apple Podcasts, Spotify, YouTube, RadioMD, and other major podcast platforms. @y_tolkach @ChemUniCologne @Sciencedirect #ScienceDirect @TheUSCAP @ESP_Pathology @AACR @IARCWHO @PennPathLabMed #PrecisionPathology #LungAdenocarcinoma #ComputationalPathology #DigitalPathology #TumorMicroenvironment #AI #WSI #NSCLC #cellularneighberhoods

Post attachment
Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Oct 21

A @NatMetabolism paper by Daniel Powell, PhD & Roddy O'Connor, PhD provides a clue to why T-cell-based immunotherapies don’t work very well against ovarian cancers, showing the impact of the ovarian cancer tumor environment & suggesting a new strategy. 🔬: nature.com/articles/s42255-0…

Penn Path & Lab Medicine avatar
Penn Path & Lab Medicine@PennPathLabMed·Oct 19

Wonderful to have Dr. Annette Kim (back) on campus today to give an engaging Grand Rounds talk! It was a packed house and our team greatly appreciated her thoughtful take on addressing the gaps in precision medicine.

Post attachment
Zubair Baloch avatar
⟳ Penn Path & Lab Medicine retweeted
Zubair Baloch@aakasharmand·Oct 14

So proud of our @PennPathLabMed trainees working on this project @ktmontone @DrNetto @IACytology @DiagnosticCyto @CancerCytopath @EfcsYoung karger.com/acy/article/doi/1…